⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

ARWR

Arrowhead Pharmaceuticals, Inc.

Healthcare · Biotechnology

58.02USD

-0.3400 (-0.58%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on ARWR.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End09/2025
Last Quarter End06/2026 Q3
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 58.02
P/E—
Dvd Ind Yld0.0%
P/B17.56
P/S12.2
Curr EV/T12M EBITDA-39.8
Mkt Cap (USD)8.2B
Curr EV (USD)8.0B
2)

Per Share Data

EPS T12M-2.25
DPS—
Bk Val Per Sh3.30
Rev/Sh4.67
Cash/Sh11.31
Curr Shares Out140.9M
FCF/Sh-0.52
3)

Cash Flow Analysis

P/CF-138.4
Curr P/FCF-108.8
CF/NI0.2
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales-8.8%
Eff Interest Rate6.7%
4)

Growth Potential

Dil EPS 1Y Gr99.8%
Cap 1Y Gr151.3%
BPS 1Y Gr125.1%
R&D To Sales108.0%
Retention Rate100.0%
Rev 1Y Gr23258.2%
FCF 1Y Gr126.0%
Assets 1Y Gr21.5%
5)

Profitability

EBITDA-0.2B
EBIT-0.2B
Operating Margin-33.8%
Pretax Margin-37.7%
Net Margin-47.8%
ROA-18.3%
ROE-64.8%
ROC—
Asset Turnover0.38
6)

Structure

Current Ratio5.90
Quick Ratio5.71
Debt/Assets65.3%
Debt/Com Eq296.3%
Net Debt/EBITDA-6.55
Tot Debt/Capital74.8%
Gross Margin100.0%
EBIT/Int Exp-2.4

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.